Is elevated high-density lipoprotein cholesterol always good for coronary heart disease?

Clinical Cardiology

Volumn 30, Issue 11, 2007, Pages 576-580

  Sun, Yuhua ^a   Yang, Yuejin ^a   Pei, Weidong ^a   Wu, Yongjian ^a   Zhao, Jinglin ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

Coronary heart disease; High density lipoprotein cholesterol; Resting unstable angina

Indexed keywords

C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY OBSTRUCTION; DIABETES MELLITUS; FEMALE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; UNSTABLE ANGINA PECTORIS;

AGED; ANGINA, UNSTABLE; ANTIOXIDANTS; ARYLDIALKYLPHOSPHATASE; BLOOD PRESSURE; C-REACTIVE PROTEIN; CHOLESTEROL; CHOLESTEROL, HDL; CORONARY ARTERY DISEASE; CORONARY DISEASE; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; REGRESSION ANALYSIS; RISK FACTORS;

EID: 36749100840     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.20137     Document Type: Article

References (20)

1. Ansell BJ, Watson KE, Fogelman AM, Navab M, Fonarow GC: High-density lipoprotein function: recent advances. J Am Coll Cardiol 2005;46:1792-1798
2. Navab M, Ananthramaiah GM, Reddy ST, Van Lenten BJ, Ansell BJ, et al.: The double jeopardy of HDL. Ann Med 2005;37:173-178
3. Manninen V, Elo MO, Frick MH, Haapa K, Heinonen OP, et al.: Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study. JAMA 1988;260:641-651
4. Robins SJ, Collins D, Wittes JT, Papademetriou V, Deedwania PC, et al.: Relation of gemfibrozil treatment and lipid levels with major coronary events. JAMA 2001;285:1585-1591
5. Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, et al.: Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels. JAMA 1998;279:1615-1622
6. Rubins HB, Robins SJ, Collins D, Fye CL, Anderson JW, et al.: Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. N Engl J Med 1999;341:410-418
7. Agerholm-Larsen B, Nordestgaard BG, Steffensen R, Jensen G, Tybjaerg-Hansen A: Elevated HDL cholesterol is a risk factor for ischemic heart disease in white women when caused by a common mutation in the cholesteryl ester transfer protein gene. Circulation 2000;101:1907-1912
8. Bittner V, Simon JA, Fong J, Blumenthal RS, Newby K, et al.: Correlates of high HDL cholesterol among women with coronary heart disease. Am Heart J 2000;139:288-296
9. Milochevitch C, Khalil A: Study of the paraoxonase and platelet-activating factor acetylhydrolase activities with aging. Prostaglandins Leukot Essent Fatty Acids 2001;65:241-246
10. Seres I, Paragh G, Deschene E, Fulop T Jr, Khalil A: Study of factors influencing the decreased HDL associated PON1 activity with aging. Exp Gerontol 2004;39:59-66
11. Corti MC, Guralnik JM, Salive ME, Harris T, Field TS, et al.: HDL cholesterol predicts coronary heart disease mortality in older persons. JAMA 1995;274:539-544
12. Curb JD, Abbott RD, Rodriguez BL, Masaki K, Chen R, et al.: A prospective study of HDLC and cholesteryl ester transfer protein gene mutations and the risk of coronary heart disease in the elderly. J Lipid Res 2004;45:948-953
13. Jaouad L, de Guise C, Berrougui H, Cloutier M, Isabelle M, et al.: Age-related decrease in high-density lipoproteins antioxidant activity is due to an alteration in the PONI's free suifhydyl groups. Atherosclerosis 2006;185:191-200
14. Navab M, Anantharamaiah GM, Fogelman AM: The role of high-density lipoprotein in inflammation. Trends Cardiovasc Med 2005;15:158-161
15. Miwa K, Fujita M, Sasayama S: Recent insights into the mechanisms, predisposing factors, and racial difference of coronary vasospasm. Heart Vessels 2005;20:1-7
16. Hsu LA, Ko YL, Hsu KH, Ko YH, Lee YS: Genetic variations in the cholesteryl ester transfer protein gene and high density lipoprotein cholesterol levels in Taiwanese Chinese. Hum Genet 2002;110:57-63
17. Zheng K, Zhang S, Zhang L, He Y, Liao L, et al.: Carriers of three polymorphisms of cholesteryl ester transfer protein gene are at increased risk to coronary heart disease in a Chinese population. Int J Cardiol 2005;103:259-265
18. Castellani LW, Navab M, Van Lenten BJ, Hedrick CC, Hama SY, et al.: Overexpression of apolipoprotein All in transgenic mice converts high density lipoproteins to proinflammatory particles. J Clin Invest 1997;100:464-474
19. Nicholls SJ, Tuzcu EM, Schoenhagen P, Sipahi I, Crowe T, et al.: Effect of atorvastatin (80 mg/day) versus pravastatin (40 mg/day) on arterial remodeling at coronary branch points (from the REVERAL study). Am J Cardiol 2005;96:1636-1639
20. Niccoli G, Renda G, Cianflone D, Crea F: Transient microvascular vasoconstriction: a possible cause of unstable angina. Ital Heart J 2000;1:365-367